A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2018
Price : $35 *
At a glance
- Drugs MEDI 3250 (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms ICICLE
- Sponsors MedImmune
- 23 Jul 2018 Planned End Date changed from 13 Apr 2018 to 30 Mar 2020.
- 23 Jul 2018 Planned primary completion date changed from 13 Apr 2018 to 30 Mar 2020.
- 04 Oct 2017 Results related to US data for 2005-16 influenza season published in the Clinical Infectious Diseases